Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Novel mechanisms to inhibit HIV reservoir seeding using Jak inhibitors
Christina Gavegnano, Jessica H. Brehm, Franck P. Dupuy, et al.
PLoS Pathogens (2017) Vol. 13, Iss. 12, pp. e1006740-e1006740
Open Access | Times Cited: 86

Showing 1-25 of 86 citing articles:

COVID-19: Discovery, diagnostics and drug development
Tarik Asselah, David Durantel, Éric Pasmant, et al.
Journal of Hepatology (2020) Vol. 74, Iss. 1, pp. 168-184
Open Access | Times Cited: 412
Targeting the Latent Reservoir for HIV-1
Srona Sengupta, Robert F. Siliciano
Immunity (2018) Vol. 48, Iss. 5, pp. 872-895
Open Access | Times Cited: 314
Block-And-Lock Strategies to Cure HIV Infection
Greet Vansant, Anne Bruggemans, Julie Janssens, et al.
Viruses (2020) Vol. 12, Iss. 1, pp. 84-84
Open Access | Times Cited: 139
Targeted Systemic Therapies for Adults with Atopic Dermatitis: Selecting from Biologics and JAK Inhibitors
Richard W. Kim, Megan Lam, Katrina Abuabara, et al.
American Journal of Clinical Dermatology (2024) Vol. 25, Iss. 2, pp. 179-193
Closed Access | Times Cited: 19
Sustained HIV remission after allogeneic hematopoietic stem cell transplantation with wild-type CCR5 donor cells
Asier Sáez‐Cirión, Anne‐Claire Mamez, Véronique Avettand-Fènoël, et al.
Nature Medicine (2024)
Closed Access | Times Cited: 15
HIV “shock and kill” therapy: In need of revision
Erik Abner, Albert Jordan
Antiviral Research (2019) Vol. 166, pp. 19-34
Closed Access | Times Cited: 142
Translational and clinical advances in JAK-STAT biology: The present and future of jakinibs
Massimo Gadina, Catrina Johnson, Daniella M. Schwartz, et al.
Journal of Leukocyte Biology (2018) Vol. 104, Iss. 3, pp. 499-514
Open Access | Times Cited: 140
The potential of JAK/STAT pathway inhibition by ruxolitinib in the treatment of COVID-19
Bakiye Göker Bağca, Çığır Biray Avcı
Cytokine & Growth Factor Reviews (2020) Vol. 54, pp. 51-61
Open Access | Times Cited: 106
Type I interferon signaling, regulation and gene stimulation in chronic virus infection
Sabelo Lukhele, Giselle M. Boukhaled, David G. Brooks
Seminars in Immunology (2019) Vol. 43, pp. 101277-101277
Open Access | Times Cited: 105
JAK-STAT Pathway: A Novel Target to Tackle Viral Infections
Ifeanyi Jude Ezeonwumelu, Edurne García-Vidal, Ester Ballana
Viruses (2021) Vol. 13, Iss. 12, pp. 2379-2379
Open Access | Times Cited: 68
Kinases as Potential Therapeutic Targets for Anti-coronaviral Therapy
Thanigaimalai Pillaiyar, Stefan Laufer
Journal of Medicinal Chemistry (2021) Vol. 65, Iss. 2, pp. 955-982
Closed Access | Times Cited: 60
Baricitinib: From Rheumatoid Arthritis to COVID‐19
Sara Assadiasl, Yousef Fatahi, Banafsheh Mosharmovahed, et al.
The Journal of Clinical Pharmacology (2021) Vol. 61, Iss. 10, pp. 1274-1285
Open Access | Times Cited: 57
Biological ageing with HIV infection: evaluating the geroscience hypothesis
Monty Montano, Krisann K. Oursler, Ke Xu, et al.
The Lancet Healthy Longevity (2022) Vol. 3, Iss. 3, pp. e194-e205
Open Access | Times Cited: 47
JAK/STAT signaling pathway affects CCR5 expression in human CD4 + T cells
Lingyun Wang, Yunus Yükselten, Julius Nuwagaba, et al.
Science Advances (2024) Vol. 10, Iss. 12
Open Access | Times Cited: 8
JAK–STAT Targeting Offers Novel Therapeutic Opportunities in Sepsis
Raphaël Clère-Jehl, Alexandre Mariotte, Ferhat Meziani, et al.
Trends in Molecular Medicine (2020) Vol. 26, Iss. 11, pp. 987-1002
Open Access | Times Cited: 51
Interferon functional analog activates antiviral Jak/Stat signaling through integrin in an arthropod
Jie Gao, Bao-Rui Zhao, Hui Zhang, et al.
Cell Reports (2021) Vol. 36, Iss. 13, pp. 109761-109761
Open Access | Times Cited: 47
Randomized Trial of Ruxolitinib in Antiretroviral-Treated Adults With Human Immunodeficiency Virus
Vincent C. Marconi, Carlee Moser, Christina Gavegnano, et al.
Clinical Infectious Diseases (2021) Vol. 74, Iss. 1, pp. 95-104
Open Access | Times Cited: 45
HIV Reservoirs and Treatment Strategies toward Curing HIV Infection
Kouki Matsuda, Kenji Maeda
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 5, pp. 2621-2621
Open Access | Times Cited: 7
Baricitinib reverses HIV-associated neurocognitive disorders in a SCID mouse model and reservoir seeding in vitro
Christina Gavegnano, Woldeab B. Haile, Selwyn J. Hurwitz, et al.
Journal of Neuroinflammation (2019) Vol. 16, Iss. 1
Open Access | Times Cited: 49
Targeting Inflammation to Reduce Atherosclerotic Cardiovascular Risk in People With HIV Infection
Boghuma K Titanji, Christina Gavegnano, Priscilla Y. Hsue, et al.
Journal of the American Heart Association (2020) Vol. 9, Iss. 3
Open Access | Times Cited: 48
Inside Perspective of the Synthetic and Computational Toolbox of JAK Inhibitors: Recent Updates
Adriana Coricello, Francesco Mesiti, Antonio Lupia, et al.
Molecules (2020) Vol. 25, Iss. 15, pp. 3321-3321
Open Access | Times Cited: 44
Filgotinib suppresses HIV-1–driven gene transcription by inhibiting HIV-1 splicing and T cell activation
Yang-Hui Jimmy Yeh, Katharine M. Jenike, Rachela Calvi, et al.
Journal of Clinical Investigation (2020) Vol. 130, Iss. 9, pp. 4969-4984
Open Access | Times Cited: 39
HIV-1 Latency and Viral Reservoirs: Existing Reversal Approaches and Potential Technologies, Targets, and Pathways Involved in HIV Latency Studies
Sushant Khanal, Madison Schank, Mohamed El Gazzar, et al.
Cells (2021) Vol. 10, Iss. 2, pp. 475-475
Open Access | Times Cited: 35
Recent Developments in the Use of Kinase Inhibitors for Management of Viral Infections
Rinky Raghuvanshi, Sandip B. Bharate
Journal of Medicinal Chemistry (2021) Vol. 65, Iss. 2, pp. 893-921
Closed Access | Times Cited: 34
Breaking the Silence: Regulation of HIV Transcription and Latency on the Road to a Cure
Natasha N. Duggan, Tatjana Dragic, Sumit K. Chanda, et al.
Viruses (2023) Vol. 15, Iss. 12, pp. 2435-2435
Open Access | Times Cited: 13
Page 1 - Next Page

Scroll to top